Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline
1 other identifier
interventional
100
1 country
1
Brief Summary
This study investigates the neural mechanisms of cognitive function decline, cognitive assessment methods for subjects with mild cognitive dysfunction (Mild cognitive impairment, MCI, or cognitive decline milder than MCI), and the approaches used to improve and restore cognitive function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2021
CompletedStudy Start
First participant enrolled
August 6, 2021
CompletedFirst Posted
Study publicly available on registry
August 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 22, 2025
May 1, 2025
5.4 years
August 1, 2021
May 20, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Change in Cognitive function (SCD-9)
The SCD-9 questionnaire is used to assess cognitive function of participants.
Change from Baseline Cognitive test results at 3 months.
Change in Cognitive function (MoCA)
The Montreal Cognitive Assessment test is used to assess cognitive function of participants.
Change from Baseline Cognitive test results at 3 months.
Change in Cognitive function (AD8)
The AD8 test is used to assess cognitive function of participants.
Change from Baseline Cognitive test results at 3 months.
Change in Cognitive function (CDR)
The Clinical Dementia Rating (CDR) test is used to assess cognitive function of participants.
Change from Baseline Cognitive test results at 3 months.
Secondary Outcomes (2)
Change in Physical capacity (TUG)
Change from Baseline physical capacity test results at 3 months.
Change in Physical capacity (chair standing)
Change from Baseline physical capacity test results at 3 months.
Other Outcomes (1)
Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
Up to 24 months.
Study Arms (2)
Control
NO INTERVENTIONControl group, without specific treatments
Cognitive training
EXPERIMENTALThis group receives treatments to improve cognitive function.
Interventions
The Intervention group will be given recommended interventions tailored to individuals based on their risks (e.g., physical exercise programs, cognitive training, dietary advice, control of blood pressure and cholesterol, healthy diet, control obesity, stop smoking,reduce alcohol excess)
Eligibility Criteria
You may qualify if:
- Adults being able to walk at least a block, and
- Adults with subjective cognitive decline (SCD), or
- Adults with mild cognitive impairment (MCI), or
- Adults with normal cognitive function
You may not qualify if:
- Clinical diagnosis of dementia
- Adults who cannot follow the protocal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Research Center for Rehabilitation Technical Aidslead
- Nanjing Brain Hospitalcollaborator
- The Third People's Hospital of Yunnan Provincecollaborator
- Central South Universitycollaborator
- Beijing academy of science and technologycollaborator
- Beijing University of Chinese Medicinecollaborator
Study Sites (1)
National Research Center for Rehabilitation Technical Aids
Beijing, Beijing Municipality, 100176, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pengxu Wei
National Research Center for Rehabilitation Technical Aids
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
August 1, 2021
First Posted
August 20, 2021
Study Start
August 6, 2021
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 22, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share